Matches in Nanopublications for { ?s ?p "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_assertion description "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090800.RARzTjAgiq0uj4aR5Ccb5TLecVf-qzJM0ALmJzfkBYqTo130_provenance.
- NP1099059.RAxyKV2qHlyA59t2DAdcBuLIXYtvzzDxPG1x3NrRkU-PM130_assertion description "[This approach has been successfully employed in the clinical approval of crizotinib for the treatment of ALK-rearranged non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1099059.RAxyKV2qHlyA59t2DAdcBuLIXYtvzzDxPG1x3NrRkU-PM130_provenance.